Handicap Neuromusculaire: Physiopathologie, Biotechnologies et Pharmacologie appliquées (END-ICAP)

Laboratory presentation

The research carried out END-ICAP focuses on the study of physiopathological processes of neuromuscular diseases and their effects on movement, respiratory and sexual activity. Thanks to its many industrial partners (Pelvipharm, Synthena ...) and its place among many international collaboration networks, most of their research reaches clinical trials.